• LAST PRICE
    42.7100
  • TODAY'S CHANGE (%)
    Trending Up0.1600 (0.3760%)
  • Bid / Lots
    40.0100/ 2
  • Ask / Lots
    45.0000/ 10
  • Open / Previous Close
    42.5300 / 42.5500
  • Day Range
    Low 39.5700
    High 43.6700
  • 52 Week Range
    Low 12.4500
    High 67.2100
  • Volume
    408,402
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 42.55
TimeVolumePRAX
09:32 ET75442.53
09:34 ET1028043
09:36 ET2396041.62
09:38 ET2189941.42
09:39 ET29941.41
09:41 ET1402740.715
09:43 ET30040.755
09:45 ET30040.86
09:50 ET1210140.825
09:52 ET1466439.72
09:56 ET13640.425
09:57 ET100040.59
09:59 ET44640.638
10:01 ET10040.49
10:03 ET20041
10:06 ET72541.2
10:08 ET70040.6301
10:10 ET20841.205
10:14 ET159941.06
10:15 ET60041.83
10:21 ET2390741.31
10:24 ET1742240.33
10:26 ET30040.32
10:30 ET20440.38
10:32 ET40040.33
10:35 ET10040.06
10:37 ET10040.42
10:39 ET20040.61
10:42 ET12440.227
10:46 ET50040.375
10:48 ET89940.3595
10:53 ET205740.09
10:55 ET30040.21
10:57 ET10039.9901
11:02 ET130340.42
11:06 ET10040.395
11:08 ET20040.77
11:11 ET70041.36
11:15 ET20040.775
11:22 ET100041.395
11:26 ET45041.32
11:31 ET10041.67
11:33 ET10041.71
11:36 ET40041.76
11:40 ET129741.85
11:44 ET40041.825
11:45 ET40041.825
11:47 ET10041.975
11:56 ET170041.95
11:58 ET40041.965
12:05 ET20041.98
12:07 ET10042.19
12:16 ET50042.135
12:18 ET40042.13
12:20 ET30042.13
12:21 ET83742.13
12:23 ET258942.6
12:25 ET100042.575
12:27 ET30042.575
12:34 ET30042.73
12:36 ET169642.42
12:38 ET80042.23
12:41 ET38242.18
12:43 ET40042.18
12:45 ET10042.18
12:48 ET129242.04
12:50 ET30042.13
12:54 ET565742.13
12:56 ET278241.95
12:57 ET10042.09
12:59 ET80041.79
01:01 ET21641.8
01:08 ET20042.18
01:12 ET10042.03
01:14 ET10041.87
01:15 ET20041.99
01:17 ET10042.0036
01:24 ET10042
01:28 ET51042.03
01:30 ET468542.08
01:32 ET231441.9
01:33 ET113341.8501
01:37 ET71942.055
01:44 ET37242.055
01:46 ET30042.21
01:48 ET10042.055
01:50 ET236442.25
01:51 ET45142.22
01:55 ET10042.215
01:57 ET149842.23
02:04 ET160042.435
02:09 ET237042.42
02:11 ET415042.22
02:13 ET20042.2
02:15 ET30042.2
02:20 ET62842.19
02:22 ET180242.13
02:24 ET40041.885
02:26 ET30041.85
02:27 ET46041.85
02:29 ET30041.855
02:31 ET73641.705
02:38 ET20041.615
02:42 ET60041.73
02:44 ET90241.89
02:45 ET70041.895
02:47 ET70041.655
02:49 ET30041.66
02:51 ET90041.655
02:54 ET70041.655
03:02 ET97241.78
03:03 ET10041.795
03:05 ET50041.82
03:12 ET78641.725
03:14 ET170041.675
03:16 ET101741.85
03:23 ET20041.995
03:25 ET31041.96
03:27 ET100042.03
03:30 ET139542
03:32 ET40042.06
03:34 ET2328442.72
03:36 ET100042.735
03:38 ET140042.75
03:39 ET60042.75
03:41 ET70042.84
03:43 ET110042.81
03:45 ET153443
03:48 ET234643.08
03:50 ET299943.105
03:52 ET179643.3
03:54 ET895543.575
03:56 ET514142.91
03:57 ET647742.74
03:59 ET689642.71
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPRAX
Praxis Precision Medicines Inc
727.9M
-2.7x
---
United StatesSSII
SS Innovations International Inc
723.9M
-30.3x
---
United StatesLYEL
Lyell Immunopharma Inc
703.6M
-3.0x
---
United StatesHLVX
Hillevax Inc
703.1M
-4.0x
---
United StatesIGMS
IGM Biosciences Inc
677.0M
-2.3x
---
United StatesDNTH
Dianthus Therapeutics Inc
676.5M
-6.8x
---
As of 2024-05-23

Company Information

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. It is focused on translating insights from genetic epilepsies into the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is applying genetic insights to the discovery and development of therapies for neurological disorders through two platforms, using its understanding of shared biological targets and circuits in the brain. Its platform includes Cerebrum, a small molecule platform, which utilizes deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies, and Solidus, is an antisense oligonucleotide platform, is an efficient, targeted precision medicine discovery and development engine anchored on a proprietary, computational methodology. Its product candidates include ulixacaltamide, PRAX-562, PRAX-628 and elsunersen.

Contact Information

Headquarters
99 High Street, 30th FloorBOSTON, MA, United States 02110
Phone
617-300-8460
Fax
302-655-5049

Executives

Independent Chairman of the Board
Dean Mitchell
President, Chief Executive Officer, Director
Marcio Souza
Chief Financial Officer
Timothy Kelly
General Counsel, Corporate Secretary
Alex Nemiroff
Independent Director
Jeffrey Chodakewitz

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$727.9M
Revenue (TTM)
$2.2M
Shares Outstanding
17.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.74
EPS
$-15.91
Book Value
$7.92
P/E Ratio
-2.7x
Price/Sales (TTM)
331.6
Price/Cash Flow (TTM)
---
Operating Margin
-5,930.21%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.